Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma

Current Oncology

Volumn 16, Issue 1, 2009, Pages 71-75

  Campos, S ^a   Davey, P ^a   Hird, A ^a   Pressnail, B ^b   Bilbao, J ^a   Aviv, R I ^a   Symons, S ^a   Pirouzmand, F ^a   Sinclair, E ^a   Culleton, S ^a   Desa, E ^a   Goh, P ^a   Chow, Edward ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Royal Victoria Hospital Barrie   (Canada)

Author keywords

Brain metastasis; Glioblastoma multiforme; Unknown primary; WBRT; Whole brain radiation therapy

Indexed keywords

DEXAMETHASONE; TEMOZOLOMIDE;

ADULT; APHASIA; BRAIN BIOPSY; BRAIN EDEMA; BRAIN METASTASIS; BRAIN RADIATION; CANCER OF UNKNOWN PRIMARY SITE; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CRANIOTOMY; DYSPHAGIA; FEMALE; GLIOBLASTOMA; HEADACHE; HUMAN; HUMAN TISSUE; MUCOSA INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; REVIEW; SPEECH DISORDER; THRUSH; TUMOR DIFFERENTIATION; VISUAL FIELD DEFECT;

EID: 65749119386     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. 2nd ed. Lyon, France: IARC Press; 2000.
2. Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: Brain and other central nervoRs system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999;91:1382-90. [Erratum in: J Natl Cancer Inst 1999;91:1693]
3. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003;361:323-31.
4. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003;29:533-40.
5. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-8.
6. Cairncross JG, Posner JB. The management of brain metastases. In: Walker MD, ed. Oncology of the Nervous System. Boston: Kluwer Boston; 1983.
7. Kehrli P. Epidemiology of brain metastases [French]. Neurochirurgie 1999;45:357-63.
8. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470-6.
9. Sheehan J, Niranjan A, Flickinger JC, Kondziolka D, Lunsford LD. The expanding role of neurosurgeons in the management of brain metastases. Surg Neurol 2004;62:32-41.
10. Vecht CJ. Clinical management of brain metastasis. J Neurol 1998;245:127-31.
11. Subramanian A, Harris A, Piggott K, Shieff C, Bradford R. Metastasis to and from the central nervous system - the "relatively protected site." Lancet Oncol 2002;3:498-507.
12. Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990;11:785-91.
13. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: Double-dose delayed CT vs. contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991;12:293-300.
14. Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: A comprehensive review. Crit Rev Oncol Hematol 2004;52:199-215.
15. Srikanth SG, Jayakumar PN, Chandrashekar HS. CT features of intracranial metastases of unknown primaries. Neurol India 2002;50:282-5.
16. Pearl ML, Talgat G, Valea FA, Chalas E. Psychiatric symptoms due to brain metastases. Med Update Psychiatr 1998;3:91-4.
17. Posner JB. Management of brain metastases. Rev Neurol 1992;148:477-87.
18. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
19. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 202;222:715-21.
20. 18F-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med 2002;43:1432-7.
21. Schwartz KM, Erickson BJ, Lucchinetti C. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 2006;48:143-9.
22. Loeffler JS, Patchell RA, Sawaya R. Treatment of metastatic cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997.
23. Lohr F, Pirzkall A, Hof H, Fleckenstein K, Debus J. Adjuvant treatment of brain metastases. Semin Surg Oncol 2001;20:50-6.
24. Voorhies RM, Sundaresan N, Thaler HT. The single supratentorial lesion. An evaluation of preoperative diagnostic tests. J Neurosurg 1980;53:364-8.
25. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high grade gliomas and metastatic brain tumors. Am J Neuroradiol 2003;24:937-41.
26. Tsao MN, Lloyd NS, Wong RK, on behalf of the Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-Based Care. Clinical practice guideline on the optimal radiotherapeutic management of brain metastases. BMC Cancer 2005;5:34.
27. Krex D, Klink B, Hartmann C, et al., on behalf of the German Glioma Network. Long-term survival with glioblastoma multiforme. Brain 2007;130:2596-606.
28. McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 2003;98:1745-8.
29. Smith JS, Jenkins RB. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 2000;5:D213-31.
30. Sawaya R. Extent of resection in malignant gliomas: A critical summary. J Neurooncol 1999;42:303-5.
31. Walker MD, Alexander E Jr, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49:333-43.
32. Glioma Meta-Analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma. Cochrane Database Syst Rev 2002;:CD003913.
33. Combs SE, Gutwein S, Schulz-Ertner D, et al. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol 2005;181:372-7.
34. Stupp R, Mason WP, van den Bent MJ, et al., on behalf of the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, and the National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.